
Three Gene Therapy Stocks Worth Watching Amid Industry Uncertainties: A Detailed Analysis
Sarepta Therapeutics Inc: A 23.2% Plunge to $77.86 – An In-depth Analysis Sarepta Therapeutics Inc (SRPT), a biopharmaceutical company specializing in RNA-based therapeutics for rare genetic diseases, has experienced a significant decline in its stock price. At the time of writing, the share price hovers around $77.86, marking a 23.2% decrease from the previous closing…